PuSH - Publication Server of Helmholtz Zentrum München

149 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Hammerl, P. ; Chaker, A.M. ; Prehn, C. ; Schmidt-Weber, C.B. & Esser-von Bieren, J.: Targeted metabolomics reveals novel lipid and amino acid metabolism alterations in aspirin-exacerbated respiratory disease. Allergy 72, 85-85 (2017)
42.
Jacobs, L.A.* et al.: A study of Myc-regulated metabolic changes in transformed B cells. Oncol. Res. Treat. 40, 218-218 (2017)
43.
Jäger, S.* et al.: Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes. Sci. Rep. 7:6037 (2017)
44.
Molnos, S. et al.: Metabolite ratios as potential biomarkers for type 2 diabetes: A DIRECT study. Diabetologia 61, 117-129 (2017)
45.
Rotter, M. et al.: Stability of targeted metabolite profiles of urine samples under different storage conditions. Metabolomics 13:4 (2017)
46.
Siskos, A.P.* et al.: Interlaboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma. Anal. Chem. 89, 656-665 (2017)
47.
Standl, M. et al.: Association of atopic dermatitis with cardiovascular risk factors and diseases. J. Invest. Dermatol. 137, 1074-1081 (2017)
48.
Standl, M. et al.: Association of atopic dermatitis with cardiovascular risk factors and diseases. Allergy 72, 53-53 (2017)
49.
Stratmann, B.* et al.: Metabolomic signature of coronary artery disease in type 2 diabetes mellitus. Int. J. Endocrinol. 2017:7938216 (2017)
50.
Suarez-Diez, M.* et al.: Plasma and serum metabolite association networks: Comparibility within and between studies using NMR and MS profiling. J. Proteome Res. 16, 2547-2559 (2017)
51.
Tokarz, J. et al.: Endocrinology meets metabolomics: Achievements, pitfalls, and challenges. Trends Endocrinol. Metab. 28, 705-721 (2017)
52.
Ward-Caviness, C.K. et al.: Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers. Heart 103, 1278-1285 (2017)
53.
Auer, M.K.* et al.: 12-months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: A targeted metabolomics study. Sci. Rep. 6:37005 (2016)
54.
Bachlechner, U.* et al.: Associations of anthropometric markers with serum metabolites using a targeted metabolomics approach: Results of the EPIC-Potsdam study. Nutr. Diabetes 6:e215 (2016)
55.
Conlon, T.M. et al.: Metabolomics screening identifies reduced L-carnitine to be associated with progressive emphysema. Clin. Sci. 130, 273-287 (2016)
56.
Dietrich, S.* et al.: Random survival forest in practice: A method for modelling complex metabolomics data in time to event analysis. Int. J. Epidemiol. 45, 1406-1420 (2016)
57.
Eden, M.* et al.: Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression. Nat. Commun. 7:11317 (2016)
58.
Eden, M.* et al.: Erratum: Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression. Nat. Commun. 7:11835 (2016)
59.
Frankó, A. et al.: Bezafibrate improves insulin sensitivity and metabolic flexibility in STZ-treated diabetic mice. Diabetes 65, 2540-2552 (2016)
60.
Fuchs, H. et al.: The first Scube3 mutant mouse line with pleiotropic phenotypic alterations. Genes Genomes Genetics G3 6, 4035-4046 (2016)